{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:56:01Z","timestamp":1792691761397,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":2389,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1111\/j.1477-2574.2010.00182.x","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T09:36:40Z","timestamp":1444729000000},"page":"302-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Surgical treatment of hepatocellular carcinoma: expert consensus statement"],"prefix":"10.1016","volume":"12","author":[{"given":"William","family":"Jarnagin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"D'Angelica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nagorney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0015","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199903113401001","article-title":"Rising incidence of hepatocellular carcinoma in the United States","volume":"340","author":"El-Serag","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0030","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000094436.34556.ac","article-title":"Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan","volume":"238","author":"Esnaola","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0035","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.1840070408","article-title":"Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics","volume":"7","author":"Infante-Rivard","year":"1987","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0040","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.sla.0000171032.99149.fe","article-title":"Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors","volume":"242","author":"Mulier","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1148\/radiol.2343040153","article-title":"Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver","volume":"234","author":"Lu","year":"2005","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.21933","article-title":"Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?","volume":"47","author":"Livraghi","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"Chen","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0065","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1245\/s10434-008-0071-3","article-title":"Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation","volume":"15","author":"Heckman","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0070","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/lt.20636","article-title":"Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era","volume":"12","author":"Porrett","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0075","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/JB.186.12.4000-4013.2004","article-title":"Role of the anti-sigma factor SpoIIAB in regulation of sigmaG during Bacillus subtilis sporulation","volume":"186","author":"Serrano","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0080","first-page":"313","article-title":"Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles","volume":"7","author":"Curley","year":"2008","journal-title":"J Exp Ther Oncol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-3155-6-2","article-title":"Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells","volume":"6","author":"Gannon","year":"2008","journal-title":"J Nanobiotechnology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0090","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cncr.23155","article-title":"Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field","volume":"110","author":"Gannon","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/bjs.4018","article-title":"Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma","volume":"90","author":"Wei","year":"2003","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0100","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","article-title":"Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths","volume":"229","author":"Fan","year":"1999","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.soc.2008.02.002","article-title":"Liver resection for hepatocellular carcinoma","volume":"17","author":"Bryant","year":"2008","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0110","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","article-title":"Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths","volume":"229","author":"Fan","year":"1999","journal-title":"Ann Surg."},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0115","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00000658-199712000-00007","article-title":"Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study","volume":"226","author":"Man","year":"1997","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0120","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1053\/j.gastro.2004.09.039","article-title":"Hepatocellular carcinoma: current surgical management","volume":"127","author":"Song","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/13651820410024067","article-title":"Surgical treatment of hepatocellular carcinoma","volume":"7","author":"Belghiti","year":"2005","journal-title":"HPB (Oxford)"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00000658-200004000-00014","article-title":"Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal","volume":"231","author":"Poon","year":"2000","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.sla.0000231758.07868.71","article-title":"Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial","volume":"245","author":"Shi","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1245\/ASO.2005.06.004","article-title":"Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database","volume":"12","author":"Ng","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.surg.2004.12.012","article-title":"Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study","volume":"137","author":"Pawlik","year":"2005","journal-title":"Surgery"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0150","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/cncr.21415","article-title":"Outcome of partial hepatectomy for large (>10cm) hepatocellular carcinoma","volume":"104","author":"Liau","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e3181904988","article-title":"Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection","volume":"249","author":"Yang","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.sla.0000086548.84705.ef","article-title":"Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation","volume":"238","author":"Cha","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","article-title":"Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation","volume":"235","author":"Poon","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0170","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.sla.0000098621.74851.65","article-title":"Resection prior to liver transplantation for hepatocellular carcinoma","volume":"238","author":"Belghiti","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0175","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00534-009-0120-8","article-title":"Laparoscopic liver resection: a systematic review","volume":"16","author":"Vigano","year":"2009","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/SLA.0b013e3181b3b2d8","article-title":"The international position on laparoscopic liver surgery: The Louisville Statement, 2008","volume":"250","author":"Buell","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0185","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0190","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000658-200204000-00012","article-title":"Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters","volume":"235","author":"Roayaie","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0195","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jlts.2003.50086","article-title":"Liver organ allocation for hepatocellular carcinoma: are we sure?","volume":"9","author":"Marsh","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0200","series-title":"Investigators Booklet and Protocol","article-title":"A randomized prospective multiinstitutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma","year":"1998"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0205","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/lt.21329","article-title":"Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?","volume":"13","author":"Roayaie","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0210","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1600-6143.2006.01411.x","article-title":"Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation","volume":"6","author":"Sharma","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0220","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1600-6143.2008.02351.x","article-title":"Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria","volume":"8","author":"Yao","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archsurg.140.5.459","article-title":"Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease","volume":"140","author":"Goodman","year":"2005","journal-title":"Arch Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0230","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/SLA.0b013e3181b2b195","article-title":"Prognostic significance of the DNA-index in liver transplantation for hepatocellular carcinoma in cirrhosis","volume":"250","author":"Jonas","year":"2009","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0235","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/jlts.2002.34892","article-title":"Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1053\/jlts.2002.34923","article-title":"Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0245","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0250","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/j.1600-6143.2007.01863.x","article-title":"Treatment of HCC in patients awaiting liver transplantation","volume":"7","author":"Schwartz","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0255","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jamcollsurg.2006.06.016","article-title":"Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival","volume":"203","author":"Bharat","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","article-title":"Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation","volume":"248","author":"Chapman","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.sla.0000090449.87109.44","article-title":"Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?","volume":"238","author":"Adam","year":"2003","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0275","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0280","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0285","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/lt.20099","article-title":"Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization","volume":"10","author":"Maddala","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0290","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/jlts.2003.50106","article-title":"Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome","volume":"9","author":"Graziadei","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0295","first-page":"492","article-title":"A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma","volume":"18","author":"Mabed","year":"2009","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camma","year":"2002","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0310","series-title":"A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma","author":"Gish","year":"2009"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0315","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","article-title":"Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study","volume":"240","author":"Mazzaferro","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0320","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s00270-007-9003-z","article-title":"Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence","volume":"30","author":"Murakami","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0325","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1148\/radiol.2523081676","article-title":"Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?","volume":"252","author":"Shibata","year":"2009","journal-title":"Radiology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0330","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000218347","article-title":"Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation","volume":"27","author":"Mahnken","year":"2009","journal-title":"Dig Dis"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-230X-9-31","article-title":"Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma","volume":"9","author":"Bouza","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0340","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.gassur.2005.09.008","article-title":"Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality","volume":"9","author":"Teh","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0345","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/gut.50.1.123","article-title":"Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation","volume":"50","author":"Llovet","year":"2002","journal-title":"Gut"},{"key":"10.1111\/j.1477-2574.2010.00182.x_bb0355","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/lt.20526","article-title":"A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation","volume":"11","author":"Yao","year":"2005","journal-title":"Liver Transpl"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15302999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X15302999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:53:00Z","timestamp":1761263580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X15302999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1365182X15302999"],"URL":"https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00182.x","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical treatment of hepatocellular carcinoma: expert consensus statement","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1477-2574.2010.00182.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}